Take a ride on the evotec "data-driven r&d autobahn to cures"

We recently hosted Innovation Week 2021 - 5 virtual sessions over 5 days which discussed:

  • How Evotec is using data and science across treatment modalities to accelerate innovation in the area of precision medicine to deliver enhanced speed, lower cost, and predictive efficacy

  • Our efforts in AI/ML in the design and development of both small molecules and antibodies, the importance of  biomarker development, targeting RNA, and our approaches to target validation

Click the buttons in the right hand column to stream the sessions on demand.

Program

Session 1

Drug discovery in the Evotec multiverse: Knowledge-driven integrated R&D

Adam Davenport | EVP, Head of Global Molecular Discovery
Tim James | VP, Head of Data Science
Christophe Boldron | VP, Head of Molecular Architects

 

Session 2

The importance of precision medicine: How biomarkers optimize translation from bench to bedside and back

Elizabeth van der Kam | SVP, Translational Biomarkers
Christoph Schaab | SVP, Head of Proteomics and Metabolomics

 

Session 3

The early bird catches the helix: Expanding the druggable target space to RNA

Steffen Grimm | Group Leader, Hit ID and Biophysics
Hilary Brooks | Senior Research Scientist, In Vitro Pharmacology


 

Session 4

Do firefighters cause fires? Establishing real disease associations through target validation

Hauke Cornils | VP, Early Discovery

Ken Young | Group Leader, In Vitro Pharmacology

 

Session 5



 

 Translate your idea into product: AI-driven antibody discovery at Evotec

Barbara Bachler-Konetzki | Group Leader, In Vitro Pharmacology
Randal Ketchem | SVP, Discovery and Molecular Design
Maria Pilla | EVP, Global Head of Preclinical Development

 

All sessions are moderated by Christophe Muller, EVP, Global Head of Business Development and Ryan Brady, EVP, Head of Business Development